Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Differentiation syndrome associated with enasidenib (AG-221), a selective inhibitor of mutant isocitrate dehydro-genase 2 (mIDH2)
    Meeting Abstract

    Fathi, A. T.; DiNardo, C. D.; Kline, I.; Kenvin, L.; Gupta, I.; Attar, E. C.; Stein, E. M.; de Botton, S.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia: Initial results from the BFORE trial
    Meeting Abstract

    Brümmendorf, T. H.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Reilly, L.; Jeynes-Ellis, A.; Leip, E.; Bardy-Bouxin, N.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Enasidenib (AG-221) in mutant-IDH2 relapsed or refractory acute myeloid leukemia (R/R AML): Results of a phase 1 dose-escalation and expansion study
    Meeting Abstract

    Stein, E. M.; DiNardo, C. D.; Pollyea, D. A.; Fathi, A. T.; Roboz, G. J.; Altman, J. K.; Stone, R. M.; Flinn, I. W.; Kantarjian, H. M.; Collins, R.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Senechal, B.; Wang, Y.; Santomasso, B.; Sadelain, M.; Brentjens, R.
    Haematologica (2017)

    Fulltext@MSK | Save
  • Vadastuximab talirine plus hypomethylating agents: A well-tolerated regimen with high remission rate in frontline older patients with acute myeloid leukemia
    Meeting Abstract

    Ravandi, F.; Stein, A.; Erba, H.; Lancet, J.; Stein, E.; Faderl, S.; Walter, R.; Advani, A.; DeAngelo, D.; Kovacsovics, T.; more...
    Haematologica (2017)

    Fulltext@MSK | Save
  • A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
    Journal Article

    Chang, A. Y.; Dao, T.; Gejman, R. S.; Jarvis, C. A.; Scott, A.; Dubrovsky, L.; Mathias, M. D.; Korontsvit, T.; Zakhaleva, V.; Curcio, M.; more...
    Journal of Clinical Investigation (2017)

    Fulltext@MSK | Save
  • Acute myeloid leukemia, version 3.2017: Clinical Practice Guidelines in Oncology
    Journal Article

    O'Donnell, M. R.; Tallman, M. S.; Abboud, C. N.; Altman, J. K.; Appelbaum, F. R.; Arber, D. A.; Bhatt, V.; Bixby, D.; Blum, W.; Coutre, S. E.; more...
    Journal of the National Comprehensive Cancer Network (2017)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor treatment for newly diagnosed chronic myeloid leukemia
    Journal Article

    Radich, J. P.; Mauro, M. J.
    Hematology/Oncology Clinics of North America (2017)

    Fulltext@MSK | Save
  • Overview of transgenic mouse models of myeloproliferative neoplasms (MPNs)
    Journal Article

    Dunbar, A.; Nazir, A.; Levine, R.
    Current Protocols in Pharmacology (2017)

    Fulltext@MSK | Save
  • Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells
    Journal Article

    Durham, B. H.; Roos-Weil, D.; Baillou, C.; Cohen-Aubart, F.; Yoshimi, A.; Miyara, M.; Papo, M.; Hélias-Rodzewicz, Z.; Terrones, N.; Ozkaya, N.; more...
    Blood (2017)

    Fulltext@MSK | Save